Sphere Fluidics Limited

📣 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠... 𝐂𝐲𝐭𝐨-𝐌𝐢𝐧𝐞®𝐂𝐇𝐑𝐎𝐌𝐀 🍾 The next evolution in single-cell analysis, built to accelerate workflows and expand applications across biotherapeutic discovery and development. At Sphere Fluidics, we’re excited to announce Cyto-Mine®Chroma, our next-generation platform designed to streamline your processes with 𝐦𝐮𝐥𝐭𝐢𝐩𝐥𝐞𝐱𝐢𝐧𝐠 𝐜𝐚𝐩𝐚𝐛𝐢𝐥𝐢𝐭𝐢𝐞𝐬, greater assay flexibility, and a 𝐅𝐎𝐔𝐑-𝐜𝐨𝐥𝐨𝐮𝐫 𝐥𝐚𝐬𝐞𝐫 𝐬𝐲𝐬𝐭𝐞𝐦 for deeper analysis. 🚀 “By combining multiplexing with our best-in-class cell throughput for functional screening of viable cells, the Cyto-Mine®Chroma platform will be a powerful new tool for our customers and will help them shave months off of their project timelines,” added Richard Hammond, CTO, Sphere Fluidics. 🔬 𝐊𝐞𝐲 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐬: • 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞𝐱𝐢𝐧𝐠 𝐂𝐚𝐩𝐚𝐛𝐢𝐥𝐢𝐭𝐢𝐞𝐬: Analyze multiple targets in one step with our upgraded four-color laser system. • 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐒𝐢𝐧𝐠𝐥𝐞-𝐂𝐞𝐥𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: Screen and assess millions of cells in a single day with picodroplet technology. • 𝐓𝐚𝐫𝐠𝐞𝐭 𝐂𝐞𝐥𝐥 𝐒𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧: Identify and dispense your desired viable cells faster and with higher accuracy, cutting project timelines by months. Get ready for Cyto-Mine®Chroma – launching Q1 2025! 🔗 𝐕𝐢𝐬𝐢𝐭 𝐭𝐡𝐞 𝐂𝐲𝐭𝐨-𝐌𝐢𝐧𝐞®𝐂𝐇𝐑𝐎𝐌𝐀 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐩𝐚𝐠𝐞: https://bit.ly/4dtmGBi 👀 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞: https://bit.ly/4ds250y #biotech #cellanalysis #multiplexing #biotherapeutics #innovation

1 week to go! Meet us at Cell & Gene 2024 📍We’ll be at Booth #27 from November 6-8 in London. Join us for a presentation by Frank Gesellchen, Assay Development Manager at Sphere Fluidics, on Accelerating Drug Development with our 2nd Generation Cyto-Mine® platform. 📅Weds. 6 Nov. 17:25pm Track: Cell Line Engineering & Development We’ll also be discussing our next-generation platform, Cyto-Mine® Chroma, coming in 2025! Plus, check out our latest poster presentation! Highlights Include: ✅ Faster project completion ✅ Multiplexing capabilities ✅ Rapid identification and isolation of rare cells ✅ Assurance of monoclonality Can't make it? You can preview the poster here: https://bit.ly/3A7850U #LifeScience #Innovation #PEGS2024 #Automation OxfordGlobal Conferences UK

🚀 Cutting Biotherapeutic Development Timelines with Advanced Microfluidics, Featured in Technology Networks! 🚀 Our VP of Commercial EMEA, Dr. Graeme Daniels, recently spoke with Technology Networks about how Sphere Fluidics is accelerating timelines in antibody discovery and biotherapeutics using cutting-edge droplet-based microfluidics technology. Graeme discusses our upcoming Cyto-Mine® Chroma platform, it’s multiplexing capabilities and its potential for transforming clone selection workflows for faster insights that are essential to high-stakes discovery. 🔬 Read the full article for an inside look at the latest innovations in single-cell screening and the future of cell and gene therapy: https://bit.ly/3AebNpI #Biotherapeutics #Microfluidics #CytoMineChroma

🌟 Curiosity Ignites Innovation at SLAS 2025! 🌟 Are you attending SLAS 2025? We are, and we’re excited to bring something game-changing to San Diego! 📅 Join us from January 25-29, 2025 as we unveil Cyto-Mine® Chroma, our latest breakthrough in single-cell analysis, designed to power next-generation discoveries in life sciences. SLAS 2025 promises to be an inspiring event, where innovators from around the world showcase the latest in laboratory automation, omics technologies, and biomarker discovery. Whether you're curious about our newest tech or the future of scientific discovery, this is the place to be! 👉 More info / sign up: https://bit.ly/4hBpjVl #SLAS2025 #CytoMineChroma #SingleCellAnalysis #LaboratoryAutomation  

1 week to go, meet us at PEGS 2024 in Barcelona! 📍We’ll be at Booth #1119 from November 5-7. Join us for a presentation by Maryam Ahmadi, Director of Science at Sphere Fluidics, on Accelerating Drug Development with our 2nd Generation Cyto-Mine® platform. 📅 Thurs. 7 Nov. 16:10pm Track: Protein Process Development We’ll also be discussing our next-generation platform, Cyto-Mine®Chroma, coming in 2025! Plus, check out our latest poster presentation! Highlights Include: ✅ Faster project completion ✅ Multiplexing capabilities ✅ Rapid identification and isolation of rare cells ✅ Assurance of monoclonality 🔗Can't make it? You can preview the poster here: https://bit.ly/3A7850U #LifeScience #Innovation #PEGS2024 #Automation

🌟Watch Jessica Hall, Senior Field Application Scientist, present our latest poster at Drug Discovery 2024, captured by Rizwan Chaudhrey. 🎥 Our poster highlights the power of Cyto-Mine® for single-cell analysis, selection, and isolation—ensuring monoclonality through advanced imaging. As Jessica explains: “Key in our cell line development is monoclonality assurance. Each picodroplet has 5 images taken to guarantee monoclonality is achieved.” 🔬 Key topics covered: ✅ The use of multiplexed assays to isolate valuable cells ✅ Increased efficiency in gene integration and clone selection ✅ High-throughput B cell screening for antibody discovery ✅ Cyto-Mine® Chroma: our next-gen platform launching in 2025, featured in the poster with its advanced multiplexing capabilities Find rare and valuable variants faster while reducing timelines by 2-3 months. Download the poster here: https://bit.ly/3A7850U #Biologics #Microfluidics #DrugDiscovery

👀 See you in 2 weeks at PEGS 2024 - held in Barcelona! 📍 Visit us at Booth #1119 and hear about our upcoming platform, Cyto-Mine® Chroma, launching in 2025. 🔬 Don’t miss our presentation on Accelerating Drug Development with our 2nd Generation Cyto-Mine® platform by Maryam Ahmadi Ahmed - Direct or Science at Sphere Fluidics. 🔗Book a meeting: https://bit.ly/4eBnqWj #LifeScience #PEGS2024 #Innovation Cambridge Healthtech Institute

We’re very excited to hear that The Good Plant Company has won a silver award for their project here at Sphere Fluidics in the plants@work awards! 🌿 Since our office renovation in May 2023, The Good Plant Company has transformed our workspace into a vibrant and collaborative environment, providing and maintaining the beautiful plants that fill our office. ✨ In August, we were honored to show the Royal Horticultural Society the luscious work The Good Plant Company had created in our office. Fast forward to October, and they’ve been awarded a silver for their project with us, alongside a gold for their project with Raspberry Pi. 🏆 A big congratulations and thank you! #LifeScience #Innovation #BioTech

Rob Treanor, our VP of Operations, has been selected to speak at the prestigious LogiPharma Connect event in Switzerland next month! This exclusive forum brings together top pharma and med tech supply chain leaders, all focused on driving digital transformation. Rob will be discussing how operations and digital ecosystems can enhance efficiency, agility, and resilience. Well done, Rob! 👏 #LifeScience #BioTech #Microfluidics

Did you attend The Festival of Biologics held in Basel this week? If you were there, we hope you watched Elena Shvets' fantastic presentations on Wednesday! Elena presented: Picodroplets for cell line engineering and antibody discovery: a novel automation approach, alongside an engaging poster presentation. Some highlights in case you missed it: - How microfluidic-enabled picodroplets deliver integrated, user friendly, automated workflows. - Workflows where millions of individual cells can be assessed daily, and the best single cells selected – in an environment that maintains high cell viability and outgrowth. - Introduction into the next generation Cyto-Mine®, the Cyto-Mine®Chroma a platform that enables a step-change in speed and scale of working. 🔗If you missed it, you can download the poster here: https://bit.ly/4gZubTP #Biologics #FOB24 #Microfluidics